What is Eczema
Even when we do manage to get GLP-1s approved, adherence becomes the next hurdle
In cases where the desired therapeutic outcomes are less urgent or for mild health concerns, oral supplementation can be sufficient
In phase 3 clinical trials (SURPASS 1-5), the dose-dependent efficacy and safety of tirzepatide were assessed by once-weekly subcutaneous injection (5 mg, 10 mg, and 15 mg), as monotherapy or combination therapy, in individuals with T2DM
MT-1 is a relatively selective MC1R agonist compared to Melanotan 2, which has broader melanocortin receptor activity
Quercetin Ameliorates Paclitaxel-Induced Neuropathic Pain by Stabilizing Mast Cells, and Subsequently Blocking PKC-Dependent Activation of TRPV1. Acta Pharmacologica Sinica, vol